![David Altarac](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Altarac
Chief Tech/Sci/R&D Officer at
ENTASIS THERAPEUTICS HOLDINGS INC.
Profile
David Altarac is currently the Chief Medical Officer at Entasis Therapeutics, Inc. and Entasis Therapeutics Holdings, Inc. He previously held positions as SVP & Head-Regulatory, Safety & Compliance at Shire Plc, Vice President-Regulatory Affairs at NeoStem, Inc., and Vice President-Regulatory Affairs at Caladrius Biosciences, Inc. Altarac has a graduate degree from New York University, a doctorate from New York Medical College, an undergraduate degree from State University of New York at Binghamton, and a graduate degree from NYU Wagner.
David Altarac active positions
| Companies | Position | Start |
|---|---|---|
| ENTASIS THERAPEUTICS HOLDINGS INC. | Chief Tech/Sci/R&D Officer | 03/11/2019 |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Chief Tech/Sci/R&D Officer | 03/11/2019 |
Former positions of David Altarac
| Companies | Position | End |
|---|---|---|
NeoStem, Inc. /Old/
 NeoStem, Inc. /Old/ Other TransportationTransportation Operates a commercial autologous adult stem cell bank | General Counsel | 31/05/2015 |
| SHIRE | Compliance Officer | - |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | General Counsel | - |
Training of David Altarac
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Medical College
 New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeoStem, Inc. /Old/
NeoStem, Inc. /Old/ Other TransportationTransportation Operates a commercial autologous adult stem cell bank | Transportation |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NYU Wagner
 NYU Wagner Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Health Technology |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
- Stock Market
- Insiders
- David Altarac
